Generation Bio Co. (GBIO)

Last Closing Price: 0.37 (2025-06-13)

Company Description

Generation Bio Co. is a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases. The company is developing distinct and complementary platforms a potent, highly selective cell-targeted lipid nanoparticle delivery system and a novel immune-quiet DNA cargo produced by a scalable capsid-free manufacturing process which uses proprietary cell-free rapid enzymatic synthesis. Generation Bio Co. is based in CAMBRIDGE, Mass.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $19.89M
Net Income (Most Recent Fiscal Year) $-131.67M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 1.01
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.34
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -292.92%
Net Margin (Trailing 12 Months) -292.92%
Return on Equity (Trailing 12 Months) -75.84%
Return on Assets (Trailing 12 Months) -30.40%
Current Ratio (Most Recent Fiscal Quarter) 8.43
Quick Ratio (Most Recent Fiscal Quarter) 8.43
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $1.29
Earnings per Share (Most Recent Fiscal Quarter) $-0.22
Earnings per Share (Most Recent Fiscal Year) $-1.98
Diluted Earnings per Share (Trailing 12 Months) $-1.08
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 67.04M
Free Float 52.42M
Market Capitalization $24.74M
Average Volume (Last 20 Days) 0.49M
Beta (Past 60 Months) 2.66
Percentage Held By Insiders (Latest Annual Proxy Report) 21.80%
Percentage Held By Institutions (Latest 13F Reports) 95.22%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%